The Company is pleased to announce that, at the general meeting held at 11:00 a.m. on 16 February 2022, each of the Resolutions were duly passed without amendment.
Details of the poll votes cast during the meeting were as follows:
A vote withheld is not a vote in law and is therefore not counted towards the proportion of votes “for” or “against” the Resolution.
A summary of these resolutions can be found below:
Ordinary Resolutions
1. To grant the Company authority to allot Ordinary Shares up to an aggregate nominal value of £3,000,000.
Special Resolution
2. To disapply pre-emption rights in respect of Ordinary Shares up to an aggregate nominal value of £3,000,000.
Terms used in this announcement shall, unless the context otherwise requires, bear the meanings given to them in the Company’s circular dated 27 January 2022, which can be found on the Company’s website at: https://www.impactreit.uk/wp-content/uploads/2022/01/Circular-Jan-2022.pdf
FOR FURTHER INFORMATION, PLEASE CONTACT:
Impact Health Partners LLP via Maitland/AMO
Andrew Cowley
Mahesh Patel
David Yaldron
Jefferies International Limited
Tom Yeadon
Andrew Morris
Ollie Notts
Tel: +4420 7029 8000
Winterflood Securities Limited
Darren Willis
Neil Langford
Hande Derinkok
Tel: +4420 3100 0000
Maitland/AMO (Communications Adviser)
James Benjamin impacthealth-maitland@maitland.co.uk
Tel: +44 7747 113 930
JTC (UK) Limited as Company Secretary
Christopher Gibbons
Tel: +44 207 409 0181
The Company’s LEI is 213800AX3FHPMJL4IJ53.
NOTES:
Impact Healthcare REIT plc acquires, renovates, extends and redevelops high quality healthcare real estate assets in the UK and lets these assets on long-term full repairing and insuring leases to high-quality established healthcare operators which offer good quality care, under leases which provide the Company with attractive levels of rent cover.
The Company aims to provide shareholders with an attractive sustainable return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified and resilient portfolio of UK healthcare real estate assets, in particular care homes for the elderly.
The Company has a progressive dividend policy with a target to grow its annual aggregate dividend in line with the inflation-linked rental uplifts received by the Group under the terms of the rent review provisions contained in the Group’s leases in the prior financial year.
On this basis, the target total dividend for the year ending 31 December 2021 is 6.41 pence per share², a 1.91% increase over the 6.29 pence in dividends paid per ordinary share for the year ended 31 December 2020.
The Group’s Ordinary Shares were admitted to trading on the main market of the London Stock Exchange, premium segment, on 8 February 2019. The Company is a constituent of the FTSE EPRA/NAREIT index.
Neither the content of the Company’s website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.
¹ All homes have been appraised under the English EPC rating system to ensure consistency and benchmarking.
² This is a target only and not a profit forecast. There can be no assurance that the target will be met and it should not be taken as an indicator of the Company’s expected or actual results.
